Literature DB >> 2567459

Induction of hyperthyroidism by interferon-alpha-2b.

M Schultz, R Müller, A von zur Mühlen, G Brabant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2567459     DOI： 10.1016/s0140-6736(89)90157-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  Thyroid dysfunction and liver injury following alpha-interferon treatment of chronic viral hepatitis.

Authors:  B Berris; S V Feinman
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

2.  Interferon-alpha therapy may induce insulin autoantibody development in patients with chronic viral hepatitis.

Authors:  E di Cesare; M Previti; F Russo; S Brancatelli; M C Ingemi; R Scoglio; N Mazzù; D Cucinotta; G Raimondo
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

Review 3.  [Interferon therapy and autoimmunity].

Authors:  J Fritzsch; J Krug; H J Heberling
Journal:  Med Klin (Munich)       Date:  1997-05-15

4.  Sustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis C.

Authors:  P Marcellin; M Pouteau; P Renard; J M Grynblat; N Colas Linhart; P Bardet; B Bok; J P Benhamou
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

Review 5.  Clinical use of sensitive assays for thyroid-stimulating hormone.

Authors:  P A Masters; R J Simons
Journal:  J Gen Intern Med       Date:  1996-02       Impact factor: 5.128

6.  Thyroid autoantibodies and thyroid dysfunction during treatment with interferon-alpha for chronic hepatitis C.

Authors:  K Kiehne; S Kloehn; H Hinrichsen; B Gallwitz; H Mönig
Journal:  Endocrine       Date:  1997-06       Impact factor: 3.633

Review 7.  Diagnostic markers of viral hepatitis B and C.

Authors:  C Trépo; F Zoulim; C Alonso; M A Petit; C Pichoud; L Vitvitski
Journal:  Gut       Date:  1993       Impact factor: 23.059

8.  Thyroid dysfunction in Chinese hepatitis C patients: Prevalence and correlation with TPOAb and CXCL10.

Authors:  Ren-Wen Zhang; Cui-Ping Shao; Na Huo; Min-Ran Li; Hong-Li Xi; Min Yu; Xiao-Yuan Xu
Journal:  World J Gastroenterol       Date:  2015-09-07       Impact factor: 5.742

9.  Effects of type I-interferons on human thyroid epithelial cells derived from normal and tumour tissue.

Authors:  E Selzer; A Wilfing; V Sexl; M Freissmuth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-09       Impact factor: 3.000

Review 10.  Clinical toxicity of the interferons.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.